Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan
- PMID: 15030702
- PMCID: PMC3322922
- DOI: 10.3201/eid1002.030731
Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan
Abstract
Severe acute respiratory syndrome (SARS) has raised a global alert since March 2003. After its causative agent, SARS-associated coronavirus (SARS-CoV), was confirmed, laboratory methods, including virus isolation, reverse transcriptase-polymerase chain reaction (RT-PCR), and serologic methods, have been quickly developed. In this study, we evaluated four serologic tests ( neutralization test, enzyme-linked immunosorbent assay [ELISA], immunofluorescent assay [IFA], and immunochromatographic test [ICT]) for detecting antibodies to SARS-CoV in sera of 537 probable SARS case-patients with correlation to the RT-PCR. With the neutralization test as a reference method, the sensitivity, specificity, positive predictive value, and negative predictive value were 98.2%, 98.7%, 98.7%, and 98.4% for ELISA; 99.1%, 87.8%, 88.1% and 99.1% for IFA; 33.6%, 98.2%, 95.7%, and 56.1% for ICT, respectively. We also compared the recombinant-based western blot with the whole virus-based IFA and ELISA; the data showed a high correlation between these methods, with an overall agreement of >90%. Our results provide a systematic analysis of serologic and molecular methods for evaluating SARS-CoV infection.
Figures
Similar articles
-
Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).J Pharm Pharm Sci. 2008 Apr 19;11(2):1s-13s. doi: 10.18433/j3j019. J Pharm Pharm Sci. 2008. PMID: 19203466 Free PMC article.
-
Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals.Ann N Y Acad Sci. 2006 May;1067(1):500-5. doi: 10.1196/annals.1354.072. Ann N Y Acad Sci. 2006. PMID: 16804033 Free PMC article. Review.
-
[Diagnostic tests: SARS-Corona virus].Nihon Rinsho. 2005 Jul;63 Suppl 7:343-5. Nihon Rinsho. 2005. PMID: 16111269 Review. Japanese. No abstract available.
-
Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients.Clin Diagn Lab Immunol. 2004 Mar;11(2):287-91. doi: 10.1128/cdli.11.2.287-291.2004. Clin Diagn Lab Immunol. 2004. PMID: 15013977 Free PMC article.
-
Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients.J Biomed Sci. 2004 Jan-Feb;11(1):117-26. doi: 10.1007/BF02256554. J Biomed Sci. 2004. PMID: 14730215 Free PMC article.
Cited by
-
Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.N Engl J Med. 2023 Oct 26;389(17):1590-1600. doi: 10.1056/NEJMoa2209502. Epub 2023 Oct 25. N Engl J Med. 2023. PMID: 37889107 Free PMC article. Clinical Trial.
-
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy.iScience. 2023 Jul 21;26(7):107056. doi: 10.1016/j.isci.2023.107056. Epub 2023 Jun 7. iScience. 2023. PMID: 37346049 Free PMC article.
-
Recent advances in immunoassay technologies for the detection of human coronavirus infections.Front Cell Infect Microbiol. 2023 Jan 4;12:1040248. doi: 10.3389/fcimb.2022.1040248. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36683684 Free PMC article. Review.
-
Silent Antibodies Start Talking: Enhanced Lateral Flow Serodiagnosis with Two-Stage Incorporation of Labels into Immune Complexes.Biosensors (Basel). 2022 Jun 21;12(7):434. doi: 10.3390/bios12070434. Biosensors (Basel). 2022. PMID: 35884237 Free PMC article.
-
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.Front Immunol. 2022 May 31;13:863554. doi: 10.3389/fimmu.2022.863554. eCollection 2022. Front Immunol. 2022. PMID: 35711445 Free PMC article.
References
-
- CDC SARS Investigative Team. Fleischauer AT, Outbreak of severe acute respiratory syndrome—worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:226–8. - PubMed
-
- Cumulative number of SARS probable cases. WHO. [Accessed July 3, 2003] Available from: URL: http://www.who.int/csr/sars/country/2003_06_25 /en/.
-
- Cumulative number of SARS probable cases in Taiwan, SARS online information center, Center for Disease Control, Taiwan. [Accessed August 2, 2003] Available from: URL: http://www.cdc.gov.tw/sarsen.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous